Pricing Log in Create free account
Saturday 17 October 2026 Export VEEV’s income statement to Excel — free account

Veeva Systems Inc.

VEEV Healthcare Health Information Services

Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025. In the quarter to July 2026, revenue grew 17.6%, EPS grew 36.6% and free cash flow was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years, operating cash flow growth for ten.

310.30 2.73 −0.87%
Market cap
$50.7B
P/E
50.0×
Fwd P/E
26.9×
Dividend yield
—
F-score
7/9
Altman Z
13.57
Beneish M
−2.63
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Insider Decisions trades per month

Total sells 15.28
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — 1 — 1 2 — — 1 2 2 1
Insider Ownership 9.08%

Capital & Financial Ratios $m

Market Cap 50,680.00
Revenue 3,458.10
Net Income 1,014.77
Free Cash Flow 1,638.77
Net Debt (7,242.95)
Current Ratio 5.46 (at or above 1.5: strong)
Debt/Equity 0.00 (at or below 0.5: strong)
P/E ratio 49.97 (above 35: high)
Fwd P/E 26.90
P/S ratio 14.57 (above 10: high)
P/B ratio 6.78 (above 6: high)
Past 5Y EPS Growth 18.18% (at or above 15%: strong)
This Y EPS Growth 14.03%
Next Y EPS Growth 11.19%
Next Y revenue growth 15.48% (at or above 10%: strong)
Next 5Y EPS Growth 12.51%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 12.5×, against a ten-year median of 12.9×; over the ten years it ranged from 5.5× in 2026 to 31.9× in 2020.
P/E against its own 10 years 10.54%
10-year low 10-year high
P/S against its own 10 years 50.50%
10-year low 10-year high
P/B against its own 10 years 20.94%
10-year low 10-year high
EV/Sales against its own 10 years 46.22%
10-year low 10-year high
EV/FCF against its own 10 years 11.54%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2027 Powerpack
2026 Powerpack
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2018 Powerpack
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2024 2025 2026 Q'26
Cash 4,028 5,150 6,561 7,243
Receivables 889 1,057 1,310 566
Inventory — — — —
Other 87 101 — —
5,003 6,309 7,998 7,946
2024 2025 2026 Q'26
Payables 32 30 38 36
ST’ Debt — — — —
Other — — — —
1,179 1,398 1,637 1,456

Compound Annual Growth %

10y 5y 3y
Sales 22.82% 16.88% 14.03%
Cash Flow 33.26% 20.75% 21.94%
Earnings 32.52% 19.05% 23.06%
Book Value 30.46% 26.06% 24.75%

Revenue $m

Apr Jul Oct Jan Year
’26 883 928 — — —
’26 759 789 811 836 3,195
’25 650 676 699 721 2,747
’24 526 590 617 631 2,364
’23 505 534 552 563 2,155
’22 434 456 476 485 1,851
’21 337 354 378 397 1,465
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Apr Jul Oct Jan Year
’26 1,127 239 — — —
’26 877 238 193 107 1,415
’25 764 93 164 70 1,090
’24 506 265 83 58 911
’23 481 93 143 63 780
’22 478 119 113 54 764
’21 282 105 95 68 551
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Apr Jul Oct Jan Year
’26 1,125 231 — — —
’26 871 232 183 100 1,386
’25 755 90 160 65 1,070
’24 503 255 77 50 885
’23 479 92 137 59 767
’22 476 114 111 50 750
’21 282 100 92 68 543
Fiscal quarters ending in the months shown.

EPS $

Apr Jul Oct Jan Year
’26 1.57 1.66 — — —
’26 1.37 1.19 1.40 1.45 5.44
’25 0.98 1.04 1.13 1.18 4.32
’24 0.81 0.68 0.83 0.90 3.22
’23 0.62 0.56 0.67 1.16 3.00
’22 0.71 0.67 0.65 0.60 2.63
’21 0.54 0.58 0.60 0.64 2.36
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.8
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to January

Group Line 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Trend 2027e 2028e 2029e
Price, $
Price, $ Low 40.71 52.17 82.41 118.11 235.74 151.02 157.00 170.25 201.54 148.05

Analyst estimates 2027–2029

Powerpack
High 68.07 109.05 176.90 313.99 343.96 257.68 225.49 258.93 310.50 319.95
People
People Employees 1,794 2,171 2,553 3,501 4,506 5,482 6,744 7,172 7,291 7,928
Revenue/emp, $m 0.31 0.32 0.34 0.32 0.33 0.34 0.32 0.33 0.38 0.40
Income, $m
Income, $m Revenue 551 691 862 1,104 1,465 1,851 2,155 2,364 2,747 3,195
Gross margin, % 68.45 69.38 71.55 72.52 72.09 72.79 71.72 71.35 74.53 75.53
EBT 122 166 239 314 394 512 509 588 919 1,195
EBT margin, % 22.22 24.01 27.68 28.41 26.89 27.68 23.62 24.88 33.47 37.38
Net income 78 151 230 301 380 427 488 526 714 909
Depreciation 30 32 30 37 53 60 48 24 30 45
Per share, $
Per share, $ Revenue 4.06 4.92 5.98 7.47 9.72 12.08 13.87 14.72 16.97 19.52
Earnings 0.51 1.01 1.59 2.03 2.52 2.79 3.14 3.27 4.41 5.55
Cash flow 1.06 1.66 2.15 2.96 3.66 4.99 5.02 5.68 6.73 8.65
Capex (0.06) (0.08) (0.07) (0.03) (0.06) (0.09) (0.09) (0.16) (0.13) (0.18)
Free cash flow 1.01 1.58 2.09 2.93 3.60 4.90 4.94 5.51 6.61 8.47
Book value 4.81 6.46 8.58 11.27 15.04 19.00 23.92 28.93 36.03 44.08
Shares, m 136 140 144 148 151 153 155 161 162 164
Valuation, ×
Valuation, × P/E 73.89 62.24 68.59 71.87 112.27 84.78 54.49 63.23 52.89 36.57
P/S 10.43 12.77 18.25 19.63 29.09 19.59 12.30 14.09 13.75 10.42
P/B 8.80 9.73 12.71 13.01 18.81 12.45 7.13 7.17 6.47 4.61
EV/Sales 9.49 11.67 16.98 18.64 27.96 18.30 10.86 12.38 11.87 8.36
EV/FCF 38.28 36.29 48.64 47.53 75.50 45.15 30.51 33.07 30.49 19.28
Cash, $m
Cash, $m Operating cash flow 144 233 311 437 551 764 780 911 1,090 1,415
Capex (8) (11) (10) (4) (9) (14) (14) (26) (21) (29)
Free cash flow 137 222 301 433 543 750 767 885 1,070 1,386
Balance, $m
Balance, $m Working capital 465 706 1,032 980 1,595 2,266 2,963 3,824 4,910 6,361
Total debt — — — 55 63 55 61 — — —
Net debt (519) (762) (1,090) (1,087) (1,664) (2,376) (3,103) (4,028) (5,150) (6,561)
Shareholders’ equity 653 906 1,238 1,666 2,266 2,912 3,716 4,645 5,832 7,215
Returns, %
Returns, % ROA 9.56 14.08 15.94 15.34 14.29 12.46 11.31 9.81 10.78 11.14
ROIC 56.38 68.41 94.38 30.90 39.18 58.99 46.76 43.49 63.35 87.58
ROE 13.40 19.40 21.44 20.74 19.33 16.51 14.72 12.58 13.63 13.93
Negative figures in brackets.

All 10 years →

Fiscal years to Jan 2026 · latest quarter Jul 2026

Charts ten years each

Veeva Systems Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
VEEV Veeva Systems Inc. $50.7B 50.0× 26.9× +17.60% (above 0%: growing) +36.59% (above 0%: growing) −0.62% (below 0%: shrinking) 75.00% 29.64%
TEM Tempus AI, Inc. $12.8B — (loss-making) — (loss-making) +21.56% (above 0%: growing) n/m −153.72% (below 0%: shrinking) 64.45% (19.85%) Compare
BTSG BrightSpring Health Services, Inc. $12.3B 34.0× 37.6× +23.05% (above 0%: growing) +192.86% (above 0%: growing) −39.62% (below 0%: shrinking) 12.72% 3.37% Compare
TXG 10x Genomics $9.4B — (loss-making) — (loss-making) −12.65% (below 0%: shrinking) n/m −4.61% (below 0%: shrinking) 74.48% (12.95%) Compare
HNGE Hinge Health Inc. $8.5B 73.5× 39.4× +53.00% (above 0%: growing) n/m +441.14% (above 0%: growing) 86.44% 19.00% Compare
HQY HealthEquity, Inc. $7.7B 33.0× 30.2× +7.64% (above 0%: growing) +14.49% (above 0%: growing) −3.44% (below 0%: shrinking) 73.55% 28.14% Compare
DOCS Doximity, Inc. $5.6B 34.8× 26.2× +7.34% (above 0%: growing) −53.57% (below 0%: shrinking) −34.14% (below 0%: shrinking) 84.87% 21.48% Compare
WAY Waystar Holding Corp. $5.4B 38.0× 22.4× +18.11% (above 0%: growing) +10.53% (above 0%: growing) −52.42% (below 0%: shrinking) 69.44% 23.79% Compare
HTFL Heartflow, Inc. $4.4B — (loss-making) — (loss-making) +47.57% (above 0%: growing) n/m +62.62% (above 0%: growing) 83.00% (27.93%) Compare
Median of peers $8.1B 34.8× 30.2× +19.84% +12.51% −19.37% 74.02% 11.19%

All 51 Health Information Services stocks →

VEEV metrics, ten years each

Veeva Systems Inc. (VEEV) key facts

  • Strength: Veeva Systems Inc.’s revenue for fiscal 2026 (year ended January 2026) was $3.2 billion, up 16.3% from fiscal 2025.
  • Veeva Systems Inc. (VEEV) is a Health Information Services company in the Healthcare sector, listed on the New York Stock Exchange.
  • As of October 16, 2026, VEEV traded at $310.30, a market capitalization of $50.7 billion.
  • Return on equity was 13.9% and debt-to-equity 0.00.
  • Its Piotroski F-score is 7 out of 9 and its Altman Z-score is 13.57 (safe zone) for fiscal 2026.

Source: company filings (standardised) and stockrow calculations.

Veeva Systems Inc. (VEEV) Latest News

No news at this impact. Lower the threshold for more.
stockrow.com/VEEV · Data as of Jul 31, 2026 · For information only; not investment advice. · © 2026 stockrow.com